These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39008915)

  • 1. Vitexicarpin suppresses malignant progression of colorectal cancer through affecting c-Myc ubiquitination by targeting IMPDH2.
    Ding XJ; Cai XM; Wang QQ; Liu N; Zhong WL; Xi XN; Lu YX
    Phytomedicine; 2024 Sep; 132():155833. PubMed ID: 39008915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer.
    Zhao J; Xu J; Lv J
    Pharmacol Rep; 2019 Oct; 71(5):940-949. PubMed ID: 31454697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells.
    Taş İ; Han J; Park SY; Yang Y; Zhou R; Gamage CDB; Van Nguyen T; Lee JY; Choi YJ; Yu YH; Moon KS; Kim KK; Ha HH; Kim SK; Hur JS; Kim H
    Phytomedicine; 2019 Mar; 56():10-20. PubMed ID: 30668330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragali Radix-Curcumae Rhizoma herb pair reduces the stemness of colorectal cancer cells through HIF-2α/β-catenin pathway.
    Sun R; Sun C; Yue Z; Yin G; Zhou L; Zhang S; Zhang Y; Tang D; Tan X
    Phytomedicine; 2024 Sep; 132():155824. PubMed ID: 38941816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
    Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
    Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer.
    Zhang YF; Zhang ZH; Li MY; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Zuo HX; Jin HL; Ma J; Jin X
    Phytomedicine; 2021 Jan; 81():153425. PubMed ID: 33310309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PVT1 facilitates the growth and metastasis of colorectal cancer by sponging with miR-3619-5p to regulate TRIM29 expression.
    Sun Z; Li X; Shi Y; Yao Y
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2085. PubMed ID: 38837682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
    Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.
    Yu S; Li L; Tian W; Nie D; Mu W; Qiu F; Liu Y; Liu X; Wang X; Du Z; Chu WF; Yang B
    Br J Pharmacol; 2018 Aug; 175(15):3111-3130. PubMed ID: 29722931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
    Zhong W; Hou H; Liu T; Su S; Xi X; Liao Y; Xie R; Jin G; Liu X; Zhu L; Zhang H; Song X; Yang C; Sun T; Cao H; Wang B
    Theranostics; 2020; 10(19):8790-8806. PubMed ID: 32754278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.